Showing 751-760 of 1043 results for "".
Pharmaceutical Treatment of Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/pharmaceutical-treatment-of-parkinsons-disease/30242/The best outcomes rely on a handful of medicines and partnership among clinicians, patients, and caregivers.Iatrogenic Hypoglossal Nerve Palsy
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/iatrogenic-hypoglossal-nerve-palsy/30684/Reversible and Benign Lesions of Splenium of The Corpus Collosum
https://practicalneurology.com/diseases-diagnoses/imaging-testing/reversible-and-benign-lesions-of-splenium-of-the-corpus-collosum/30269/Aggressive diagnostic and therapeutic approaches are often unnecessary.Stroke in a Young Adult:
Immunomodulation-Responsive Bilateral Supraclinoid Carotid Artery Vasculopathy Secondary to Systemic Lupus Erythematosushttps://practicalneurology.com/diseases-diagnoses/stroke/stroke-in-a-young-adultbrimmunomodulation-responsive-bilateral-supraclinoid-carotid-artery-vasculopathy-secondary-to-systemic-lupus-erythematosus/32069/A rare case of ischemic stroke in the setting of large-vessel vasculopathy in an individual with systemic lupus erythematosus.Physical and Cognitive Activity for Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/physical-and-cognitive-activity-for-dementia/31733/There is enough evidence of the neuroprotective effects of physical and cognitive activity to recommend these to patients.Epilepsy Essentials: Cenobamate
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-cenobamate/31605/A novel GABA modulator has just been approved by the Food and Drug Administration after safety and efficacy were seen in clinical trials.Left Atrial Appendage Closure and the Neurologist
https://practicalneurology.com/diseases-diagnoses/stroke/left-atrial-appendage-closure-and-the-neurologist/30297/What neurologists need to know to ensure optimal patient selection.Filling the Gaps in the Multiple Sclerosis Treatment Landscape
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/filling-the-gaps-in-the-multiple-sclerosis-treatment-landscape/30372/The addition of a potential breakthrough agent may change the treatment arena, but wellness and early treatment remain the foundation of effective care.A Comprehensive Approach to Managing Dementia Patients: Considering the Caregivers
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/a-comprehensive-approach-to-managing-dementia-patients-considering-the-caregivers/30777/A Q&A with Richard Isaacson, MDCo-existent Optic Nerve Drusen in a Patient with Idiopathic Intracranial Hypertension
https://practicalneurology.com/columns/practice-management/PN1009_07-php/30884/Pseudotumor cerebri occurs in about one in 1,000 people, and a “cause” is often difficult to identify.